Overview

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study that when studies using our method of dosing adjustments driven by continuous glucose monitoring and because of the less variable glycemic effect of insulin detemir, insulin detemir treated subjects will spend a significantly greater time in the glucose target range than insulin glargine.
Phase:
N/A
Details
Lead Sponsor:
Diabetes Care Center
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Glargine